352 related articles for article (PubMed ID: 25965403)
1. Vitamin D deficiency--prognostic marker or mortality risk factor in end stage renal disease patients with diabetes mellitus treated with hemodialysis--a prospective multicenter study.
Schiller A; Gadalean F; Schiller O; Timar R; Bob F; Munteanu M; Stoian D; Mihaescu A; Timar B
PLoS One; 2015; 10(5):e0126586. PubMed ID: 25965403
[TBL] [Abstract][Full Text] [Related]
2. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D deficiency, mortality, and hospitalization in hemodialysis patients with or without protein-energy wasting.
Fiedler R; Dorligjav O; Seibert E; Ulrich C; Markau S; Girndt M
Nephron Clin Pract; 2011; 119(3):c220-6. PubMed ID: 21832848
[TBL] [Abstract][Full Text] [Related]
4. [REIN Report 2011--summary].
Couchoud C; Lassalle M; Jacquelinet C
Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
[TBL] [Abstract][Full Text] [Related]
5. The prognostic role of brain natriuretic peptides in hemodialysis patients.
Naganuma T; Sugimura K; Wada S; Yasumoto R; Sugimura T; Masuda C; Uchida J; Nakatani T
Am J Nephrol; 2002; 22(5-6):437-44. PubMed ID: 12381941
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D deficiency and associated factors in hemodialysis patients.
Jean G; Charra B; Chazot C
J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis.
Del Valle E; Negri AL; Aguirre C; Fradinger E; Zanchetta JR
Hemodial Int; 2007 Jul; 11(3):315-21. PubMed ID: 17576296
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D deficiency is associated with mortality and adverse vascular access outcomes in patients with end-stage renal disease.
Walker JP; Hiramoto JS; Gasper WJ; Auyang P; Conte MS; Rapp JH; Lovett DH; Owens CD
J Vasc Surg; 2014 Jul; 60(1):176-83. PubMed ID: 24582700
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of 25-hydroxivitamin D entirely explained by a higher comorbidity burden: experience from a South-Eastern European Dialysis Cohort.
Schiller A; Apetrii M; Onofriescu M; Siriopol D; Veisa G; Schiller O; Bob F; Timar R; Mihaescu A; Kanbay M; Covic A
Hemodial Int; 2015 Apr; 19(2):249-55. PubMed ID: 25251168
[TBL] [Abstract][Full Text] [Related]
10. The impact of diabetes mellitus on vitamin D metabolism in predialysis patients.
Tanaka H; Hamano T; Fujii N; Tomida K; Matsui I; Mikami S; Nagasawa Y; Ito T; Moriyama T; Horio M; Imai E; Isaka Y; Rakugi H
Bone; 2009 Nov; 45(5):949-55. PubMed ID: 19631779
[TBL] [Abstract][Full Text] [Related]
11. Vascular calcification is not related to serum fetuin-A and osteopontin levels in hemodialysis patients.
Ulutas O; Taskapan MC; Dogan A; Baysal T; Taskapan H
Int Urol Nephrol; 2018 Jan; 50(1):137-142. PubMed ID: 29134617
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
Blair D; Byham-Gray L; Lewis E; McCaffrey S
J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
[TBL] [Abstract][Full Text] [Related]
13. Low 25-OH-vitamin D levels reflect hepatic dysfunction and are associated with mortality in patients with liver cirrhosis.
Paternostro R; Wagner D; Reiberger T; Mandorfer M; Schwarzer R; Ferlitsch M; Trauner M; Peck-Radosavljevic M; Ferlitsch A
Wien Klin Wochenschr; 2017 Jan; 129(1-2):8-15. PubMed ID: 27888359
[TBL] [Abstract][Full Text] [Related]
14. Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5.
García-Canton C; Bosch E; Ramírez A; Gonzalez Y; Auyanet I; Guerra R; Perez MA; Fernández E; Toledo A; Lago M; Checa MD
Nephrol Dial Transplant; 2011 Jul; 26(7):2250-6. PubMed ID: 20956810
[TBL] [Abstract][Full Text] [Related]
15. On-line haemodiafiltration improves response to calcifediol treatment.
Pérez-García R; Albalate M; de Sequera P; Alcázar R; Puerta M; Ortega M; Corchete E
Nefrologia; 2012 Jul; 32(4):459-66. PubMed ID: 22652556
[TBL] [Abstract][Full Text] [Related]
16. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D levels, vitamin D supplementation, and prognosis in patients with chronic kidney disease
.
Namir Y; Cohen MJ; Haviv YS; Slotki I; Shavit L
Clin Nephrol; 2016 Oct; 86(10):165-74. PubMed ID: 27616756
[TBL] [Abstract][Full Text] [Related]
18. 25-Hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease.
Elder GJ; Mackun K
J Bone Miner Res; 2006 Nov; 21(11):1778-84. PubMed ID: 17002574
[TBL] [Abstract][Full Text] [Related]
19. 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy.
Coen G; Mantella D; Manni M; Balducci A; Nofroni I; Sardella D; Ballanti P; Bonucci E
Kidney Int; 2005 Oct; 68(4):1840-8. PubMed ID: 16164662
[TBL] [Abstract][Full Text] [Related]
20. Low serum intact parathyroid hormone level is an independent risk factor for overall mortality and major adverse cardiac and cerebrovascular events in incident dialysis patients.
Lee SA; Lee MJ; Ryu GW; Jhee JH; Kim HW; Park S; Jung SY; Oh HJ; Park JT; Han SH; Kang SW; Yoo TH
Osteoporos Int; 2016 Sep; 27(9):2717-2726. PubMed ID: 27216997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
